CORBUS PHARMACEUTICALS HOLDINGS, INC.

Profile

Company Names

CORBUS PHARMACEUTICALS HOLDINGS, INC.
SAV ACQUISITION CORP

Addresses

142 WEST 57TH STREET, SUITE 4A, NEW YORK, NY 10019

Phone Numbers

646-367-5905

 

Entity Type:

CORPORATION

Industry:

INVESTING

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$6,419,750.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2014-04-11 
$6,310,000.00 
$13,000,000.00 
$6,690,000.00 
Equity 
2
2014-03-05 
$19,750.00 
$30,000.00 
$10,250.00 
Equity 
1
2013-12-27 
$90,000.00 
$90,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
BRANCACCIO 
EXECUTIVE OFFICER
SYNERGY PHARMACEUTICALS, INC.   |  SYNERGY PHARMACEUTICALS, INC.   |  TROVAGENE INC.   |  ORCHESTRA CALIBER CO-INVESTMENT PARTNERS, LLC   |  CORBUS PHARMACEUTICALS HOLDINGS, INC.   |  SAV ACQUISITION CORP   |  SAV HOLDINGS CORP.   |  TAMIR BIOTECHNOLOGY, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  ADGERO BIOPHARMACEUTICALS HOLDINGS, INC.   |  RASNA THERAPEUTICS INC.   |  TROVAGENE, INC.   |  CARDIFF ONCOLOGY, INC.
YUVAL 
 
COHEN 
EXECUTIVE OFFICER, DIRECTOR
FIBERZONE NETWORKS INC   |  TRAFFIX COMMUNICATION SYSTEMS LTD.   |  MORRIA BIOPHARMACEUTICALS PLC   |  CORBUS PHARMACEUTICALS HOLDINGS, INC.   |  STAGE ONE VENTURE CAPITAL FUND II (CAYMAN), L.P.   |  ANIMATED STORYBOARDS INC.
DAVID 
 
HOCHMAN 
EXECUTIVE OFFICER, DIRECTOR
VITAL ACCESS CORP   |  ORCHESTRA CALIBER CO-INVESTMENT PARTNERS, LLC   |  PRIVATE PRACTICE, INC.   |  ORCHESTRA MOTUS CO-INVESTMENT PARTNERS, LLC   |  CORBUS PHARMACEUTICALS HOLDINGS, INC.   |  SAV ACQUISITION CORP   |  SAV HOLDINGS CORP.   |  NAKED BRAND GROUP INC.   |  ADGERO BIOPHARMACEUTICALS HOLDINGS, INC.   |  MOTUS GI HOLDINGS, INC.   |  MOTUS GI MEDICAL TECHNOLOGIES, LTD.   |  CALIBER THERAPEUTICS, INC.   |  PG REALTY PARTNERS, LLC
ALAN 
 
HOLMER 
DIRECTOR
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SEAN 
 
MORAN 
EXECUTIVE OFFICER
BUCHANAN INGERSOLL + ROONEY PC   |  CORBUS PHARMACEUTICALS HOLDINGS, INC.
MARK 
 
TEPPER 
EXECUTIVE OFFICER
JB THERAPEUTICS, INC.   |  PRIMATOPE THERAPEUTICS, INC.   |  CORBUS PHARMACEUTICALS HOLDINGS, INC.   |  RETE PAY INC.   |  EUMENTIS THERAPEUTICS, INC.
ROBERT 
 
ZURIER 
EXECUTIVE OFFICER
CORBUS PHARMACEUTICALS HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-04-23
D
Link
INVESTING 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-11 
2014-03-12
D
Link
INVESTING 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-05 
2014-01-10
D
Link
INVESTING 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
AEGIS CAPITAL CORP.
15007
NONE
NONE
N/A
NONE